Efficacy, safety and tolerability of aliskiren, a direct renin inhibitor, in women with hypertension: a pooled analysis of eight studies (Q43143679)

14 November 2017

0 references

Efficacy, safety and tolerability of aliskiren, a direct renin inhibitor, in women with hypertension: a pooled analysis of eight studies (English)

1 reference

14 November 2017

A H Gradman

1

1 reference

14 November 2017

M R Weir

2

1 reference

14 November 2017

M Wright

3

1 reference

14 November 2017

C A Bush

4

1 reference

14 November 2017

D L Keefe

5

1 reference

14 November 2017

publication date

4 March 2010

1 reference

Journal of Human Hypertension

14 November 2017

published in

1 reference

14 November 2017

volume

24

1 reference

14 November 2017

issue

11

1 reference

14 November 2017

page(s)

721-729

1 reference

https://scigraph.springernature.com/pub.10.1038/jhh.2010.11

14 November 2017

exact match

0 references

cites work

Heart disease and stroke statistics--2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2010.11

Nine-year trends and racial and ethnic disparities in women's awareness of heart disease and stroke: an American Heart Association national study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2010.11

Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2010.11

Does sex matter in the associations between classic risk factors and fatal coronary heart disease in populations from the Asia-Pacific region?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2010.11

Cardiovascular disease in women: sex differences in presentation, risk factors, and evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2010.11

Sympathetic overactivity as a cause of hypertension in chronic renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2010.11

Effect of antihypertensive drug treatment on cardiovascular outcomes in women and men. A meta-analysis of individual patient data from randomized, controlled trials. The INDANA Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2010.11

Efficacy of treating hypertension in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2010.11

Hypertension treatment and control in five European countries, Canada, and the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2010.11

Hypertension in adults across the age spectrum: current outcomes and control in the community

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2010.11

Hypertension and its treatment in postmenopausal women: baseline data from the Women's Health Initiative

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2010.11

Women and hypertension: what did we learn from the Women's Health Initiative?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2010.11

Aliskiren, a novel orally effective renin inhibitor, provides dose-dependent antihypertensive efficacy and placebo-like tolerability in hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2010.11

Aliskiren: a review of its use in the management of hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2010.11

Renin inhibition with aliskiren provides additive antihypertensive efficacy when used in combination with hydrochlorothiazide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2010.11

Comparative efficacy and safety of aliskiren, an oral direct renin inhibitor, and ramipril in hypertension: a 6-month, randomized, double-blind trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2010.11

Efficacy and safety of the direct renin inhibitor aliskiren and ramipril alone or in combination in patients with diabetes and hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2010.11

Long-term antihypertensive efficacy and safety of the oral direct renin inhibitor aliskiren: a 12-month randomized, double-blind comparator trial with hydrochlorothiazide

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2010.11

Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2010.11

Enoxaparin vs. unfractionated heparin with fibrinolysis for ST-elevation myocardial infarction in elderly and younger patients: results from ExTRACT-TIMI 25.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2010.11

Aliskiren-based therapy lowers blood pressure more effectively than hydrochlorothiazide-based therapy in obese patients with hypertension: sub-analysis of a 52-week, randomized, double-blind trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2010.11

Gender difference in blood pressure control and cardiovascular risk factors in Americans with diagnosed hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2010.11

21 January 2018

Hypertension in women

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2010.11

Menopause and hypertension: an age-old debate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2010.11

Angiotensin II type 1 receptor blockade to control blood pressure in postmenopausal women: influence of hormone replacement therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2010.11

Characteristics and treatment of hypertension in women: a review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2010.11

Randomised, double blind, multicentre comparison of hydrochlorothiazide, atenolol, nitrendipine, and enalapril in antihypertensive treatment: results of the HANE study. HANE Trial Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2010.11

Gender as a Risk Factor for Adverse Events to Medications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2010.11

Do women have more adverse drug reactions?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2010.11

Sex and racial differences in pharmacological response: where is the evidence? Pharmacogenetics, pharmacokinetics, and pharmacodynamics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2010.11

Efficacy and tolerance of antihypertensive treatment in men and women with stage 1 diastolic hypertension. Results of the Treatment of Mild Hypertension Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2010.11

Diuretic-induced severe hyponatremia. Review and analysis of 129 reported patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2010.11

Female preponderance in diuretic-associated hypokalemia: a retrospective study in seven long-term care facilities

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2010.11

Thiazide-induced hypokalaemia; prevalence higher in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2010.11

Diuretic induced hyponatraemia in elderly hypertensive women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2010.11

Aliskiren, an oral renin inhibitor, provides dose-dependent efficacy and sustained 24-hour blood pressure control in patients with hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2010.11

7 January 2021

Aliskiren, an orally effective renin inhibitor, provides antihypertensive efficacy alone and in combination with valsartan

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2010.11

7 January 2021

Aliskiren, a novel oral renin inhibitor, provides dose-dependent efficacy and placebo-like tolerability in Japanese patients with hypertension

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2010.11

7 January 2021

Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2010.11

7 January 2021

Gender-based differences in the toxicity of pharmaceuticals--the Food and Drug Administration's perspective

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2010.11

7 January 2021

Hypertension in women

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2010.11

7 January 2021

Female preponderance for lisinopril-induced cough in hypertension

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2010.11

7 January 2021

Enalapril-induced cough

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2010.11

7 January 2021

A comparison of isradipine and felodipine in Australian patients with hypertension: focus on ankle oedema. The Physician's Study Group

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2010.11

7 January 2021

Identifiers

DOI

10.1038/JHH.2010.11

1 reference

Dimensions Publication ID

14 November 2017

1020549561

0 references

1 reference